eLife (Oct 2013)

A component of the mir-17-92 polycistronic oncomir promotes oncogene-dependent apoptosis

  • Virginie Olive,
  • Erich Sabio,
  • Margaux J Bennett,
  • Caitlin S De Jong,
  • Anne Biton,
  • James C McGann,
  • Samantha K Greaney,
  • Nicole M Sodir,
  • Alicia Y Zhou,
  • Asha Balakrishnan,
  • Mona Foth,
  • Micah A Luftig,
  • Andrei Goga,
  • Terence P Speed,
  • Zhenyu Xuan,
  • Gerard I Evan,
  • Ying Wan,
  • Alex C Minella,
  • Lin He

DOI
https://doi.org/10.7554/eLife.00822
Journal volume & issue
Vol. 2

Abstract

Read online

mir-17-92, a potent polycistronic oncomir, encodes six mature miRNAs with complex modes of interactions. In the Eμ-myc Burkitt’s lymphoma model, mir-17-92 exhibits potent oncogenic activity by repressing c-Myc-induced apoptosis, primarily through its miR-19 components. Surprisingly, mir-17-92 also encodes the miR-92 component that negatively regulates its oncogenic cooperation with c-Myc. This miR-92 effect is, at least in part, mediated by its direct repression of Fbw7, which promotes the proteosomal degradation of c-Myc. Thus, overexpressing miR-92 leads to aberrant c-Myc increase, imposing a strong coupling between excessive proliferation and p53-dependent apoptosis. Interestingly, miR-92 antagonizes the oncogenic miR-19 miRNAs; and such functional interaction coordinates proliferation and apoptosis during c-Myc-induced oncogenesis. This miR-19:miR-92 antagonism is disrupted in B-lymphoma cells that favor a greater increase of miR-19 over miR-92. Altogether, we suggest a new paradigm whereby the unique gene structure of a polycistronic oncomir confers an intricate balance between oncogene and tumor suppressor crosstalk.

Keywords